Latest Blogs

Feb 23, 2021
In their roles as patient advocates, Ms. Janine Guglielmino and Dr. Sue Friedman have observed growing patient confusion about breast cancer subtypes and the difference between acquired and inherited gene mutations.
Feb 18, 2021
This is a time of significant and multi-layered anxiety, especially for our patients living with and beyond cancer. 
Feb 11, 2021
"My motto is to stand up for all the people who face casual racism, sexism, and injustice, and my aim is to protect international trainees in medicine when it is my turn to be a mentor," Dr. Viju Chandrasekhar affirms as she shares a personal experience with bias based on her accent.
Feb 11, 2021
Our oncology training is shaped by those who devote their time to helping us turn our weaknesses into strengths, and all of us have a role to play as teachers.
Subscribe to this column

Clifford A. Hudis, MD, FACP, FASCO

Clifford A. Hudis, MD, FACP, FASCO, is the CEO of ASCO, executive vice chair of Conquer Cancer, the ASCO Foundation, and chair of CancerLinQ. Prior to these roles, he served as chief of the Breast Medicine Service and an attending physician at Memorial Sloan Kettering Cancer Center and as a professor in the Department of Medicine at Weill Cornell Medical College. He is a past president of ASCO. His research interests include all areas of care related to breast cancer, with a focus on the development of novel systemic therapies and prevention interventions related to obesity and inflammation. Follow Dr. Hudis on Twitter @CliffordHudis.

Disclosure.

Jan 27, 2014
The approach of ASCO’s Annual Meeting—where we will celebrate the 50th year since our founding in 1964—brings excitement and anticipation. Your Cancer Education Committee, led by Dr. Gini Fleming, has been working hard and in collaboration with the...
Nov 12, 2013
Sometimes life and events unfold in ways that suggest the presence of planning and forethought. It is hard to be sure since, faced with randomness and coincidence, some have suggested that we have been selected through evolution to see patterns and associations even when none exist.
Oct 04, 2013
This week I had the good fortune to attend the 10th Main Meeting of the Early Breast Cancer Trialists’ Collaborative Group in Oxford, England. Known widely as “the meta-analysis” or as the “Oxford Overview,” this effort has relied on very large numbers (of randomly assigned patients) to fuel the...
Jul 25, 2013
There are a large number of great scientific and educational meetings to choose from, but the 2013 Breast Cancer Symposium, Saturday, September 7 to Monday, September 9, in San Francisco is unique. It is big enough to draw clinical and translational experts in all disciplines and informal enough to...
Jul 21, 2013
It has been very hot this week, and during spin class this morning—an activity of mine that Charles Sawyers managed to work into his Science of Oncology address at the 2013 ASCO Annual Meeting—my mind drifted away from the instructor’s...

Pages